In an ever-changing world, it is important to keep up with the latest innovations. In the never-ending search for what’s new, what better way to learn than to hear it from the innovator himself?
INFLAMMATION AND CANCER AT THE CLINIC
Frances Balkwill is Professor of Cancer Biology at Barts Cancer Institute, Queen Mary University of London, where she leads the Centre for Cancer and Inflammation and the Cytokine and Cancer Group. Dr. Balkwill is also Director of the Centre of the Cell, a biomedical sciences centre for children, and Fellow of the Academy of Medical Sciences. Her research is focused on the links between cancer and inflammation – particularly the role inflammatory cytokines play in cancer promotion – and is especially concerned with the translation of this knowledge into new biological treatments for cancer.
VIRUS AGAINST CANCER
Kevin Harrington is Professor of Biological Cancer Therapies and Joint Head of the Division of Radiotherapy and Imaging, at The Institute of Cancer Research. He is also an honorary consultant oncologist at The Royal Marsden and a Fellow of the Royal College of Physicians and of the Royal College of Radiologists. Professor Harrington is a specialist in melanoma and head and neck cancer. He leads the Targeted Therapy Team in the Division of Cancer Biology which is focused on developing new strategies to target cancer cells selectively, involving biologically targeted agents in combination with treatments such as radiotherapy and chemotherapy.
THE NEW ERA OF CANCER
Michael Lisanti is Professor of Cancer Biology and Breast Oncology, Director of the Manchester Breakthrough Breast Cancer Research Unit, and the new founding Director of the Manchester Centre for Cellular Metabolism, at the University of Manchester. Professor Lisanti was the first to propose the Reverse Warburg Effect. This new model for cancer metabolism will enable the development of novel diagnostic and therapeutic strategies towards a personalised cancer approach. Recently he has investigated the effects of antibiotics on the mitochondria of cancer stem cells, finding new pathways for the eradication of cancer cells.
STEM CELLS TREATMENT FOR OSTEOGENESIS IMPERFECTA IN UTERO
Professor and Director for the Doctoral Program in Regenerative Medicine at Karolinska Insitutet, Cecilia Göthersström runs the National Umbilical Cord Blood Bank in Sweden and is the main researcher at the Centre for Haematology and Regenerative Medicine. The use of stem cells in the clinical practice is one of the main goals of her research, particularly the potential for the cure of genetic diseases such as osteogenesis imperfecta. Her participation in the iMed Conference 8.0 will reveal the first data from the clinical phase of this study.
NONINVASIVE PRENATAL TESTING AND PRESYMPTOMATIC IDENTIFICATION OF CANCER IN PREGNANT WOMEN
Professor Frédéric Amant is a Belgian Gynaecologic Oncologist responsible for the scientific section of Gynaecological Oncology at the Catholic University of Louvain, Belgium. He leads the International Network on Cancer, Infertility and Pregnancy of the European Society of Gynaecological Oncology, is a member of the Endometrium Tumour Site Committee of the European Organization for Research and Treatment of Cancer and of the European Network Individualized Treatment in Endometrial Cancer. He is also a collaborator in numerous scientific journals such as the European Journal of Obstetrics and Gynaecology and Reproductive Biology and has authored/co-authored more than 100 scientific articles. In his participation a new non-invasive prenatal diagnosis application will be introduced to the audience.
THE EMBO KEYNOTE LECTURE
Could genetics be the basis for complex mental disorders such as schizophrenia or depression? Through his extensive research on rodent models and human genomics, Professor Jonathan Flint has contributed for a better understanding of Psychiatry. Currently at the University of California Los Angeles’ Department of Psychiatry, Professor Flint has performed most of his research work at the Wellcome Trust Centre for Human Genetics, in Oxford. With numerous articles published, and several communications, both at scientific and Economics events, his results have brought a novel perspective on the genetic basis of behavioural and mental disorders, as well as a new target for further treatments and management strategies in Modern Psychiatry.
Researchers have managed to understand how our mind can modulate our immune system. But can our immune system determine our mental health? José Oliveira, MD, PhD, is currently studying this phenomenon through his research on Psychoneuroimmunology. He graduated in Medicine from the University of Coimbra, Portugal, after what he started his residency in Psychiatry in Centro Hospitalar Psiquiátrico de Lisboa. He completed his PhD at the Translational Psychiatry Laboratory of Mondor Institut for Biomedical Research in Paris, with particular interest in the immunogenetics of psychiatric disorders and their potential interactions with environmental risk factors such as perinatal infection and childhood trauma.
Currently based in Exeter University, Professor Thorsten Barnhofer is one of the main contributors to the development of mindfulness-based techniques for patients with chronic mental diseases such as major depression. He worked alongside Professor Mark Williams at Oxford, as well as other notable references in this area, and further explored the neurobiological mechanisms underlying the treatment for chronic mental diseases, at Freie Universität Berlin. After having presented his perspective to researchers and prominent personalities such as His Holiness the 14th Dalai Lama, he will share, in this 8th edition of the iMed Conference, his most recent results and prospects for the near future.
THE NEW ERA OF AGEING
Dr. Aubrey de Grey is a biomedical gerontologist based in Cambridge, United Kingdom, and Mountain View, California, United States of America, and is currently the Chief Science Officer of SENS Research Foundation. He is also Editor-in-Chief of Rejuvenation Research, the world’s most impacting peer-reviewed journal focused on intervention in ageing. He received his BA in Computer Science and his Ph.D. in Biology from the University of Cambridge. His research interests encompass the characterization of all the accumulative, and eventually pathogenic, molecular and cellular side effects of metabolism that constitute mammalian ageing, and the designing of interventions to repair and/or obviate this damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations.
EXPERIMENTAL DEMENTIA RESEARCH
Professor Gunnar Keppler Gouras is professor of Neuroscience and group leader of the experimental Dementia Research Unit in the department of Experimental Medical Science in the Faculty of Medicine, at Lund University. The focus of his team is to elucidate the mechanisms of early synapse dysfunction in Alzheimer’s disease (AD) and related neurodegenerative disorders. His group was the first to report on β-amyloid (Aβ) accumulation in endosomes and synapses in Alzheimer’s disease, among other physiological mechanisms. Past honors include Merck Young Investigator Award in Alzheimer’s disease from the American Academy of Neurology (2001), and Temple (2003) and Zenith (2007) awards from the Alzheimer’s Association.
Professor Janet Eyre is Professor of Paediatric Neuroscience at Newcastle University in the UK. She is an internationally recognised expert in brain plasticity following brain injury, investigating the development and the factors governing plasticity of the corticospinal system throughout life and its implications in rehabilitation. She currently leads a research program studying the clinical application of video games to online physiotherapy, thus enabling home-based-delivery of therapy with expert remote monitoring and management by therapists. She has received several awards for her work, namely the Medical Futures Best Innovation to Improve Patient Care—Cardiovascular Innovation Award 2011 and the Medical Futures National Health Service Innovation of the Year Award 2012.
It is thanks to our amazing partners that we are able to host this conference!
Interested in becoming a sponsor? Get in touch!